Physician profile
Gregory Wood
NPI 1629077961
$1,250.19
in general payments reported to CMS, 2019-2025
15 companies · $18.15 in 2025
The $18.15 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $34.28 · 2021: $266 · 2022: $177 · 2023: $156 · 2024: $163 · 2025: $18.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $207.27 | 2021-2024 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $157.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $134.24 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $119.55 | 2019-2021 | |
| Pfizer INC. | $93.25 | 2020-2024 | |
| Boston Scientific Corporation | $91.38 | 2022-2024 | Bodyguardian |
| Lantheus Medical Imaging, INC. | $82.16 | 2022 | |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Medtronic, INC. | $73.46 | 2021 | |
| Abbott Laboratories | $63.82 | 2019 | |
| Braemar Manufacturing, LLC | $38.71 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.74 | 2023-2024 | Lifevest |
| Abiomed | $32.65 | 2023-2025 | Impella |
| Chiesi USA, INC. | $22.85 | 2019 | |
| Shockwave Medical, INC | $21.84 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.